{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:48:55Z","timestamp":1778780935672,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejca.2004.01.017","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T10:36:05Z","timestamp":1079519765000},"page":"1150-1158","source":"Crossref","is-referenced-by-count":79,"title":["Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy"],"prefix":"10.1016","volume":"40","author":[{"given":"C","family":"Seynaeve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C","family":"Verhoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.C","family":"van de Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Menke-Pluymers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J","family":"Meijers-Heijboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.W","family":"van den Ouweland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F","family":"Niermeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.M","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.T.M","family":"Brekelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2004.01.017_BIB1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJM198903303201302","article-title":"Eight-year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer","volume":"320","author":"Fisher","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB2","first-page":"15","article-title":"Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial","author":"van Dongen","year":"1992","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ejca.2004.01.017_BIB3","first-page":"1444","article-title":"Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials","volume":"33","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM199504063321402","article-title":"Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer","volume":"332","author":"Jacobson","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB5","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/1097-0142(19891201)64:11<2217::AID-CNCR2820641106>3.0.CO;2-2","article-title":"Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer","volume":"64","author":"Stotter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB6","first-page":"153","article-title":"Breast tumor recurrence following lumpectomy with and without breast irradiation","volume":"8","author":"Fisher","year":"1992","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0360-3016(90)90271-K","article-title":"The prognostic significance of late local recurrence after breast-conserving therapy","volume":"18","author":"Kurtz","year":"1990","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejca.2004.01.017_BIB8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0360-3016(93)90382-6","article-title":"Local recurrence versus new primary","volume":"27","author":"Haffty","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejca.2004.01.017_BIB9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00000658-199008000-00009","article-title":"Survival following locoregional recurrence after breast conservation therapy for cancer","volume":"212","author":"Stotter","year":"1990","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejca.2004.01.017_BIB10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0959-8049(94)00526-B","article-title":"Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence","volume":"31A","author":"Kemperman","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1996.14.1.52","article-title":"Ipsilateral breast tumor recurrence as a predictor of distant disease","volume":"14","author":"Haffty","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1200\/JCO.1998.16.2.480","article-title":"Skin recurrences after breast-conserving therapy for early-stage breast cancer","volume":"16","author":"Gage","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<437::AID-CNCR23>3.0.CO;2-1","article-title":"Local recurrence after breast conservation therapy for early stage breast carcinoma","volume":"85","author":"Voogd","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1005732224717","article-title":"Breast conserving surgery for invasive breast cancer","volume":"43","author":"Dalberg","year":"1997","journal-title":"Breast Cancer Res. Treatm."},{"key":"10.1016\/j.ejca.2004.01.017_BIB15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1200\/JCO.1999.17.5.1449","article-title":"Breast-conserving therapy","volume":"17","author":"Meijer-van Gelder","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB16","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1200\/JCO.1998.16.6.2045","article-title":"Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer","volume":"16","author":"Chabner","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB17","first-page":"29","article-title":"The significance of family history for patients with carcinoma of the breast","volume":"179","author":"Israeli","year":"1994","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ejca.2004.01.017_BIB18","first-page":"308","article-title":"An analysis of age and family history on outcome after breast-conservation treatment","volume":"4","author":"Haas","year":"1998","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.ejca.2004.01.017_BIB19","first-page":"302","article-title":"Local recurrence in the conservatively treated breast cancer patient","volume":"4","author":"Harrold","year":"1998","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.ejca.2004.01.017_BIB20","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"Robson","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0959-8049(99)00008-8","article-title":"Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST)","volume":"35","author":"Brekelmans","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB22","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","article-title":"Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations","volume":"91","author":"Robson","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejca.2004.01.017_BIB23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0360-3016(00)00726-4","article-title":"Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast","volume":"48","author":"Harris","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejca.2004.01.017_BIB24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1013867917101","article-title":"Familial breast cancer","volume":"1","author":"Eccles","year":"2001","journal-title":"Familial Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB25","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","article-title":"Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations","volume":"18","author":"Pierce","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2004.01.017_BIB27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/BF02557530","article-title":"Breast-conservation therapy in early-stage breast cancer patients with a positive family history","volume":"9","author":"Vlastos","year":"2002","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1","volume":"351","author":"Verhoog","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2004.01.017_BIB29","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","article-title":"Survival in hereditary breast cancer associated with germline mutations of BRCA2","volume":"17","author":"Verhoog","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199203193261201","article-title":"Cancer in the contralateral breast after radiotherapy for breast cancer","volume":"326","author":"Boice","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2004.01.017_BIB32","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/cncr.10952","article-title":"Classifying local disease recurrences after breast conservation therapy based on location and histology","volume":"95","author":"Huang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2004.01.017_BIB33","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1200\/JCO.1999.17.10.3017","article-title":"BRCA1\/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy","volume":"17","author":"Turner","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.017_BIB34","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.017_BIB36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2004.01.017_BIB37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jnci\/93.13.1008","article-title":"Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer","volume":"93","author":"Li","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejca.2004.01.017_BIB38","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804904001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804904001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:23:45Z","timestamp":1550161425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804904001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0959804904001261"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2004.01.017","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}